AZX# Phase

Related by string. * : AZX# . product platforms AZX# . clinical trials AZX# / phases . Phases . phase . PHASE . PHASES : Phase III clinical trials . Phase III trials . Phase III clinical . Phase 2b clinical . pivotal Phase III . ongoing Phase 1b . Initiates Phase II . Phase III Clinical Trial . Phase IIa clinical trials . Phase IIb clinical . multicenter Phase II . initiated Phase Ib * *

Related by context. Frequent words. (Click for all words.) 74 Pivotal Phase 68 Initiates Phase 66 Pivotal Phase III 63 Completes Enrollment 63 Metastatic Melanoma 62 Phase III Clinical Trial 62 Phase 1a 61 Phase 61 Pivotal Trial 61 Phase 1b 61 TELCYTA 59 Phase 2b study 59 Phase Ib clinical 58 confirmatory Phase III 58 HGS ETR1 58 registrational trial 58 Phase 2a clinical 58 Phase 2a 58 Phase III Trial 58 Phase 2b 58 pivotal Phase III 58 celgosivir 58 elotuzumab 58 Phase IIb 58 Phase II 58 isavuconazole 58 phase IIa 58 pivotal Phase 57 confirmatory Phase 3 57 KRN# 57 preclinical toxicology 57 phase IIb 57 Phase III 57 Ostarine 57 Clinical Trial Results 57 Phase IIa clinical 56 Phase 2a trial 56 Zerenex 56 advanced carcinoid 56 Cloretazine R VNP#M 56 Phase 2b clinical 56 MEK inhibitor 56 deforolimus 56 Phase Ib 56 CCX# 56 Phase III pivotal 56 Phase IIa trial 56 IMC A# 56 eniluracil 56 Omigard 56 Phase IIb clinical 55 Phase Ia 55 double blinded placebo 55 Azedra 55 dose escalation 55 glufosfamide 55 IND submission 55 BCX# 55 BrachySil 55 Phase 2b trial 55 phase 2a 55 Phase III clinical 55 MGCD# [001] 55 MNTX 55 oral calcitonin 55 ICA # 55 Phase 1b trial 54 sodium Injection 54 QNEXA 54 squalamine 54 Phase IIa 54 Cethrin 54 relapsed refractory multiple myeloma 54 6R BH4 54 nab paclitaxel 54 teduglutide 54 Cethromycin 54 CR# vcMMAE 54 BEMA Buprenorphine 54 By KBJR News 54 atacicept 54 valopicitabine 54 OXi# 54 Phases II 54 HspE7 54 PEG Interferon lambda 54 adecatumumab 53 dose escalation trial 53 SinuNase 53 Chrysalin 53 ocrelizumab 53 Genasense R oblimersen 53 omecamtiv mecarbil 53 drug conjugate 53 ATTRACT 53 FDA Accepts 53 pharmacodynamic effects 53 label multicenter 53 CRx 53 ISIS # 53 IND enabling

Back to home page